CDSA Schedules

• < Criminal Law

Changes to Schedules

Amendments to Schedules

Schedules

60 The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest.

– CDSA

SCHEDULE I

(Sections 2 to 7, 29, 55 and 60)

1. Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:

(1) Opium

(2) Codeine (methylmorphine)

(3) Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)

(4) Thebaine (paramorphine) and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:

(5) Acetorphine (acetyletorphine)

(6) Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)

(7) Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)

(8) Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)

(9) Desomorphine (dihydrodeoxymorphine)

(10) Diacetylmorphine (heroin)

(11) Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)

(12) Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)

(13) Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)

(14) Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)

(15) Hydrocodone (dihydrocodeinone)

(16) Hydromorphinol (dihydro–14–hydroxymorphine)

(17) Hydromorphone (dihydromorphinone)

(18) Methyldesorphine (Δ6–deoxy–6–methylmorphine)

(19) Methyldihydromorphine (dihydro–6–methylmorphine)

(20) Metopon (dihydromethylmorphinone)

(21) Morphine–N–oxide (morphine oxide)

(22) Myrophine (benzylmorphine myristate)

(23) Nalorphine (N–allylnormorphine)

(24) Nicocodine (6–nicotinylcodeine)

(25) Nicomorphine (dinicotinylmorphine)

(26) Norcodeine (N–desmethylcodeine)

(27) Normorphine (N–desmethylmorphine)

(28) Oxycodone (dihydrohydroxycodeinone)

(29) Oxymorphone (dihydrohydroxymorphinone)

(30) Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)

(31) Thebacon (acetyldihydrocodeinone)

but not including

(32) Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol) and its salts

(33) Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine) and its salts

(34) Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts

(34.1) Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts

(34.2) Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts

(34.3) Methylnaltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts

(34.4) Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts

(35) Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone) and its salts

(36) Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline) and its salts

(37) Poppy seed

2. Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:

(1) Coca leaves

(2) Cocaine (benzoylmethylecgonine)

(3) Ecgonine (3–hydroxy–2–tropane carboxylic acid)

3. Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:

(1) Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)

(2) Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)

(3) Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)

(4) Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)

(5) Betameprodine (ß–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)

(6) Betaprodine (ß–1,3–dimethyl–4–phenyl–4–piperidinol propionate)

(7) Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)

(8) Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)

(9) Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)

(10) Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)

(11) Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)

(12) Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)

(13) Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)

(14) Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)

(15) Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)

(16) Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)

(17) Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)

(18) Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)

(19) Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)

(20) Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)

(21) Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)

(22) Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate)

but not including

(23) Carperidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate) and its salts

(24) Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate) and its salts

4. Phenazepines, their salts, derivatives and salts of derivatives including:

(1) Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate)

but not including

(2) Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate) and its salts

(3) Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate) and its salts

(4) Metheptazine (methylhexahydro-1,2-dimethyl-4-phenylazepine-4-carboxylate) and its salts

5. Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

(1) Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)

(2) Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)

(3) Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)

(4) Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)

(5) Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)

(6) Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)

(7) Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)

6. Methadols, their salts, derivatives and salts of derivatives including:

(1) Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)

(2) Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)

(3) Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)

(4) Betacetylmethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)

(5) Betamethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol)

(6) Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)

(7) Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)

7. Phenalkoxams, their salts, derivatives and salts of derivatives including:

(1) Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)

(2) Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)

(3) Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)

8. Thiambutenes, their salts, derivatives and salts of derivatives including:

(1) Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)

(2) Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)

(3) Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)

9. Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

(1) Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)

(2) Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)

(3) Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)

(4) Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)

10. Morphinans, their salts, derivatives and salts of derivatives including:

(1) Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)

(2) Drotebanol (6ß,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)

(3) Levomethorphan (l–3–methoxy–17–methylmorphinan)

(4) Levorphanol (l–3–hydroxy–17–methylmorphinan)

(5) Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)

(6) Norlevorphanol (l–3–hydroxymorphinan)

(7) Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)

(8) Racemethorphan (d,1–3–methoxy–17–methylmorphinan)

(9) Racemorphan (d,l–3–hydroxy–N–methylmorphinan)

but not including

(10) Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren) and its salts

(11) Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol) and its salts

(12) Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts

(13) Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts

(14) Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and its salts

(15) Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and its salts

11. Benzazocines, their salts, derivatives and salts of derivatives including:

(1) Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)

(2) Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)

(3) Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol)

but not including

(4) Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol) and its salts

12. Ampromides, their salts, derivatives and salts of derivatives including:

(1) Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)

(2) Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)

(3) Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)

13. Benzimidazoles, their salts, derivatives and salts of derivatives including:

(1) Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)

(2) Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)

(3) Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine)

14. Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:

(1) Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)

15. Piritramide (1–(3–cyano–3,3–diphenylpropyl)–4–(1–piperidino)piperidine–4–carboxylic acid amide), its salts, derivatives and salts of derivatives

16. Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:

(1) Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)

(2) Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)

(3) Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)

(4) p–Fluorofentanyl (4'fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)

(5) Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)

(6) ß–Hydroxyfentanyl (N–[1–(ß–hydroxyphenethyl)–4–piperidyl] propionanilide)

(7) ß–Hydroxy–3–methylfentanyl (N–[1–(ß–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)

(8) α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)

(9) α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)

(10) 3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)

(11) 3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)

(11.1) Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)

(12) Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)

(13) Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)

17. Tilidine (ethyl2–(dimethylamino)–1–phenyl–3–cyclohexene–1–carboxylate), its salts, derivatives and salts of derivatives

17.1 Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

18. Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

19. Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:

(1) amphetamine (α-methylbenzene-ethanamine)

(2) N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)

(3) 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)

(4) 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)

(5) 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)

(6) 4-methoxyamphetamine (4-methoxy-α-methylbenzene­ethanamine)

(7) 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzene­ethanamine)

(8) N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)

(9) 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)

(10) 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzo­dioxole-5-ethanamine)

(11) N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)

(12) N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzo­dioxole-5-ethanamine)

(13) 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)

(14) 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)

(15) 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)

(16) 4-ethoxyamphetamine (4-ethoxy-α-methylbenzene­ethanamine)

(17) Benzphetamine (N-benzyl-N,α-dimethylbenzene­ethanamine)

(18) N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzo­dioxole-5-ethanamine)

(19) N-(2-Hydroxyethyl)-α-meth-ylbenzene­ethanamine

(20) N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxyla­mine)

(21) 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzene­ethanamine)

20. Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives

21. 4-hydroxybutanoic acid (GHB) and any of its salts

22. Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers

23. AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers

24. MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including

(1) Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)

(2) Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)

(3) Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)

(4) Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)

but not including

(5) Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers

25. W-18 (4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

26. U-47700 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide), its salts, derivatives, isomers and analogues, and salts of derivatives, isomers and analogues, including

(1) Bromadoline (4-bromo-N-(2-(dimethylamino)cyclohexyl)benzamide)

(2) U-47109 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)benzamide)

(3) U-48520 (4-chloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide)

(4) U-50211 (N-(2-(dimethylamino)cyclohexyl)-4-hydroxy-N-methylbenzamide)

(5) U-77891 (3,4-dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide)

1996, c. 19, Sch. I; SOR/97-230, ss. 1 to 6; SOR/99-371, ss. 1, 2; SOR/99-421, s. 1(E); SOR/2005-235, s. 1; SOR/2005-271, 337; 2012, c. 1, s. 44; SOR/2012-176; SOR/2015-190; SOR/2016-107, s. 1; 2017, c. 7, s. 46; SOR/2017-13, ss. 1 to 5; SOR/2017-275; SOR/2017-277, s. 1; SOR/2018-70, ss. 1, 2, 3(F).

–

SCHEDULE II

(Sections 2, 3, 4 to 7, 10, 29, 55 and 60)

1. [Repealed, 2018, c. 16, s. 204]

2. Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:

(1) Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3’-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including

(i) Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)

(ii) Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)

(iii) 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)

(iv) 5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940)

(v) 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)

(2) Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including

(i) 1-pentyl-3-(1-naphthoyl)indole (JWH-018)

(ii) 1-butyl-3-(1-naphthoyl)indole (JWH-073)

(iii) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)

(iv) 1-hexyl-3-(1-naphthoyl)indole (JWH-019)

(v) 1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)

(vi) 1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)

(vii) 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)

(viii) 1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200)

(ix) 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210)

(x) 1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)

(xi) 1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220)

(xii) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201)

(xiii) 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201)

(xiv) 1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)

(xv) ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2)

(3) Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including

(i) 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307)

(4) Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including

(i) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)

(ii) 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251)

(iii) 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302)

(5) Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including

(i) 1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233)

(6) Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including

(i) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144)

(ii) (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)

(iii) (1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260)

(7) Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including

(i) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)

(ii) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)

(8) Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including

(i) N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)

(ii) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48)

(iii) N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)

(iv) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)

(9) Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including

(i) N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)

(ii) N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA)

1996, c. 19, Sch. II; SOR/98-157; SOR/2003-32, s. 1; SOR/2015-192; 2017, c. 7, s. 47; 2018, c. 16, s. 204.

–

SCHEDULE III

(Sections 2, 4 to 7.1, 10, 29, 55 and 60)

1 [Repealed, 2012, c. 1, s. 45]

2 Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including

(1) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)

(2) Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)

(3) Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)

(4) 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)

(5) 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)

(6) 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)

(7) Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)

(8) Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)

3 Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof [PD: also referred to as "Quaaludes"]

4 Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof

5 Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof

6 N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof

7 N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof

8 N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof

9 Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof

10 Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof

11 Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof

12 Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof

13 N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof

14 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof

15 1–Phenyl–N–propylcyclohexanamine and any salt thereof

16 Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof

17 Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)

18 [Repealed, SOR/2017-249, s. 1]

19 Cathinone ((-)-α-aminopropiophenone) and its salts

20 Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof

21 2–Methylamino–1–phenyl–1–propanone and any salt thereof

22 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof

23 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof

24 [Repealed, SOR/2016-73, s. 1]

25 and 26 [Repealed, 2012, c. 1, s. 46]

27 Aminorex (5-phenyl-4,5-dihydro-1,3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including

(1) 4-Methylaminorex (4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine)

(2) 4,4’-Dimethylaminorex (4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

28 Etryptamine (3-(2-aminobutyl)indole) and any salt thereof

29 Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers

30 Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof

31 Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof

32 Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof

33 Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers

34 Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers

35 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including

(1) 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)

(2) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)

(3) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)

(4) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

1996, c. 19, Sch. III; SOR/97-230, ss. 7 to 10; SOR/98-173, s. 1; SOR/2000-220, s. 1; SOR/2003-32, ss. 2, 3, 4(F), 5; SOR/2003-412; SOR/2005-235, s. 2; 2012, c. 1, ss. 45, 46; SOR/2012-66; SOR/2016-73; SOR/2016-107, s. 2; 2017, c. 7, s. 48; SOR/2017-13, s. 6; SOR/2017-44, 249.

– {{{2}}}

SCHEDULE IV

(Sections 2, 4 to 7.1, 10, 29, 55 and 60)

1. Barbiturates, their salts and derivatives including

(1) Allobarbital (5,5–diallylbarbituric acid)

(2) Alphenal (5–allyl–5–phenylbarbituric acid)

(3) Amobarbital (5–ethyl–5–(3–methylbutyl)barbituric acid)

(4) Aprobarbital (5–allyl–5–isopropylbarbituric acid)

(5) Barbital (5,5–diethylbarbituric acid)

(6) [Repealed, SOR/2017-13, s. 7]

(7) Butabarbital (5–sec–butyl–5–ethylbarbituric acid)

(8) Butalbital (5–allyl–5–isobutylbarbituric acid)

(9) Butallylonal (5–(2–bromoallyl)–5–sec–butylbarbituric acid)

(10) Butethal (5–butyl–5–ethylbarbituric acid)

(11) Cyclobarbital (5–(1–cyclohexen–1–yl)–5–ethylbarbituric acid)

(12) Cyclopal (5–allyl–5–(2–cyclopenten–1–yl)barbituric acid)

(13) Heptabarbital (5–(1–cyclohepten–1–yl)–5–ethylbarbituric acid)

(14) Hexethal (5–ethyl–5–hexylbarbituric acid)

(15) Hexobarbital (5–(1–cyclohexen–1–yl)–1,5–dimethylbarbituric acid)

(16) Mephobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)

(17) Methabarbital (5,5–diethyl–1–methylbarbituric acid)

(18) Methylphenobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)

(19) Propallylonal (5–(2–bromoallyl)–5–isopropylbarbituric acid)

(20) Pentobarbital (5–ethyl–5–(1–methylbutyl)barbituric acid)

(21) Phenobarbital (5–ethyl–5–phenylbarbituric acid)

(22) Probarbital (5–ethyl–5–isopropylbarbituric acid)

(23) Phenylmethylbarbituric Acid (5–methyl–5–phenylbarbituric acid)

(24) Secobarbital (5–allyl–5–(1–methylbutyl)barbituric acid)

(25) Sigmodal (5–(2–bromoallyl)–5–(1–methylbutyl) barbituric acid)

(26) Talbutal (5–allyl–5–sec–butylbarbituric acid)

(27) Vinbarbital (5–ethyl–5–(1–methyl–1–butenyl)barbituric acid)

(28) Vinylbital (5–(1–methylbutyl)–5–vinylbarbituric acid) but not including

(29) Barbituric Acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts

(30) 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts

2. Thiobarbiturates, their salts and derivatives including:

(1) Thialbarbital (5–allyl–5–(2–cyclohexen–1–yl)–2–thiobarbituric acid)

(2) Thiamylal (5–allyl–5–(1–methylbutyl)–2–thiobarbituric acid)

(3) Thiobarbituric Acid (2–thiobarbituric acid)

(4) Thiopental (5–ethyl–5–(1–methylbutyl)–2–thiobarbituric acid)

3. Chlorphentermine (1–(p–chlorophenyl)–2–methyl–2–aminopropane) and any salt thereof

4. Diethylpropion (2–(diethylamino)propiophenone) and any salt thereof

5. Phendimetrazine (d–3,4–dimethyl–2–phenylmorpholine) and any salt thereof

6. Phenmetrazine (3–methyl–2–phenylmorpholine) and any salt thereof

7. Pipradrol (α,α–diphenyl–2–piperidinemethanol) and its salts

8. Phentermine (α,α–dimethylbenzeneethanamine) and any salt thereof

9. Butorphanol (l–N–cyclobutylmethyl–3,14–dihydroxymorphinan) and its salts

10. Nalbuphine (N–cyclobutylmethyl–4,5–epoxy–morphinan–3,6,14–triol) and its salts

11. Glutethimide (2–ethyl–2–phenylglutarimide)

12. Clotiazepam (5–(o–chlorophenyl)–7–ethyl–1,3–dihydro–1–methyl–2H–thieno[2,3–e]–1,4–diazepin–2–one) and any salt thereof

13. Ethchlorvynol (ethyl–2–chlorovinyl ethynyl carbinol)

14. Ethinamate (1–ethynylcyclohexanol carbamate)

15. Mazindol (5–(p–chlorophenyl)–2,5–dihydro–3H–imidazo[2,1–a]isoindol–5–ol)

16. Meprobamate (2–methyl–2–propyl–1,3–propanediol dicarbamate)

17. Methyprylon (3,3–diethyl–5–methyl–2,4–piperidinedione)

18. Benzodiazepines, their salts and derivatives, including: [PD: often referred to as "benzos"]

(1) Alprazolam (8–chloro–1–methyl–6–phenyl–4H–s–triazolo[4,3–a][1,4] benzodiazepine)

(2) Bromazepam (7–bromo–1,3–dihydro–5–(2–pyridyl)–2H–1, 4–benzodiazepin–2–one)

(2.1) Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)

(3) Camazepam (7–chloro–1,3–dihydro–3–(N,N–dimethylcarbamoyl)–1–methyl–5–phenyl–2H–1, 4–benzodiazepin–2–one)

(4) Chlordiazepoxide (7–chloro–2–(methylamino)–5–phenyl–3H–1,4–benzodiazepine–4–oxide)

(5) Clobazam (7–chloro–1–methyl–5–phenyl–1H–1,5–benzodiazepine–2,4(3H,5H)–dione)

(6) Clonazepam (5–(o–chlorophenyl)–1,3–dihydro–7–nitro–2H–1,4–benzodiazepin–2–one)

(7) Clorazepate (7–chloro–2,3–dihydro–2,2–dihydroxy–5–phenyl–1H–1,4–benzodiazepine–3–carboxylic acid)

(8) Cloxazolam (10–chloro–11b–(o–chlorophenyl)–2,3, 7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin 6–(5H)–one)

(9) Delorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)

(10) Diazepam (7–chloro–1,3–dihydro–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)

(11) Estazolam (8–chloro–6–phenyl–4H–s–triazolo [4,3–a][1,4]benzodiazepine)

(12) Ethyl Loflazepate (ethyl 7–chloro–5–(o–fluorophenyl)–2,3–dihydro–2–oxo–1H–1,4–benzodiazepine–3–carboxylate)

(13) Fludiazepam (7–chloro–5–(o–fluorophenyl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)

(14) [Repealed, SOR/98-173, s. 2]

(15) Flurazepam (7–chloro–1–[2–(diethylamino) ethyl]–5–(o–fluorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)

(16) Halazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2,2,2–trifluoroethyl)–2H–1,4–benzodiazepin–2–one)

(17) Haloxazolam (10–bromo–11b–(o–fluorophenyl)–2,3,7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin–6(5H)–one)

(18) Ketazolam (11–chloro–8,12b–dihydro–2,8–dimethyl–12b–phenyl–4H–[1,3]–oxazino–[3,2–d][1,4] benzodiazepine–4,7(6H)–dione)

(19) Loprazolam (6–(o–chlorophenyl)–2,4–dihydro–2–[(4–methyl–1–piperazinyl)methylene]–8–nitro–1H–imidazo[1,2–a][1,4]benzodiazepin–1–one)

(20) Lorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–2H–1,4–benzodiazepin–2–one)

(21) Lormetazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–1–methyl–2H–1,4–benzodiazepin–2–one)

(22) Medazepam (7–chloro–2,3–dihydro–1–methyl–5–phenyl–1H–1,4–benzodiazepine)

(22.1) Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)

(23) Nimetazepam (1,3–dihydro–1–methyl–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)

(24) Nitrazepam (1,3–dihydro–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)

(25) Nordazepam (7–chloro–1,3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)

(26) Oxazepam (7–chloro–1,3–dihydro–3–hydroxy–5–phenyl–2H–1,4–benzodiazepin–2–one)

(27) Oxazolam (10–chloro–2,3,7,11b–tetrahydro–2–methyl–11b–phenyloxazolo[3,2–d] [1,4]benzodiazepin–6(5H)–one)

(28) Pinazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2–propynyl)–2H–1,4–benzodiazepin–2–one)

(29) Prazepam (7–chloro–1–(cyclopropylmethyl)–1, 3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)

(29.1) Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)

(30) Temazepam (7–chloro–1,3–dihydro–3–hydroxy–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)

(31) Tetrazepam (7–chloro–5–(cyclohexen–1–yl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)

(32) Triazolam (8–chloro–6–(o–chlorophenyl)–1–methyl–4H–s–triazolo[4,3–a][1,4]benzodiazepine)

but not including:

(32.1) Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof

(33) Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof

(34) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts

(35) Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts

19. Catha edulis Forsk., its preparations, derivatives, alkaloids and salts, including:

(1) Cathine (d–threo–2–amino–1–hydroxy–1–phenylpropane)

20. Fencamfamin (d,l–N–ethyl–3–phenylbicyclo[2,2,1] heptan–2–amine) and any salt thereof

21. Fenproporex (d,l–3–[(α–methylphenethyl)amino]propionitrile) and any salt thereof

22. Mefenorex (d,l–N–(3–chloropropyl)–α–methylbenzeneethanamine) and any salt thereof

23. Anabolic steroids and their derivatives including:

(1) Androisoxazole (17ß–hydroxy–17α–methylandrostano [3,2–c]isoxazole)

(2) Androstanolone (17ß–hydroxy–5α–androstan–3–one)

(3) Androstenediol (androst–5–ene–3ß,17ß–diol)

(4) Bolandiol (estr–4–ene–3ß,17ß–diol)

(5) Bolasterone (17ß–hydroxy–7a,17–dimethylandrost–4–en–3–one)

(6) Bolazine (17ß–hydroxy–2a–methyl–5α–androstan–3–one azine)

(7) Boldenone (17ß–hydroxyandrosta–1,4–dien–3–one)

(8) Bolenol (19–nor–17a–pregn–5–en–17–ol)

(9) Calusterone (17ß–hydroxy–7ß,17–dimethylandrost–4–en–3–one)

(10) Clostebol (4–chloro–17ß–hydroxyandrost–4–en–3–one)

(11) Drostanolone (17ß–hydroxy–2a–methyl–5α–androstan–3–one)

(12) Enestebol (4, 17ß–dihydroxy–17–methylandrosta–1,4–dien–3–one)

(13) Epitiostanol (2a, 3a–epithio–5α–androstan–17ß–ol)

(14) Ethylestrenol (19–nor–17a–pregn–4–en–17–ol)

(15) 4–Hydroxy–19–nor testosterone

(16) Fluoxymesterone (9–fluoro–11ß,17ß–dihydroxy–17–methylandrost–4–en–3–one)

(17) Formebolone (11a, 17ß–dihydroxy–17–methyl–3–oxoandrosta–1,4 di–en–2–carboxaldehyde)

(18) Furazabol (17–methyl–5α–androstano[2,3–c] furazan–17ß–ol)

(19) Mebolazine (17ß–hydroxy–2a,17–dimethyl–5α–androstan–3–one azine)

(20) Mesabolone (17ß–[(1–methoxycyclohexyl)oxy]–5α–androst–1–en–3–one)

(21) Mesterolone (17ß–hydroxy–1a–methyl–5α–androstan–3–one)

(22) Metandienone (17ß–hydroxy–17–methylandrosta–1,4–dien–3–one)

(23) Metenolone (17ß–hydroxy–1–methyl–5α–androst–1–en–3–one)

(24) Methandriol (17α–methylandrost–5–ene–3ß,17ß–diol)

(25) Methyltestosterone (17ß–hydroxy–17–methylandrost–4–en–3–one)

(26) Metribolone (17ß–hydroxy–17–methylestra–4, 9,11–trien–3–one)

(27) Mibolerone (17ß–hydroxy–7α,17–dimethylestr–4–en–3–one)

(28) Nandrolone (17ß–hydroxyestr–4–en–3–one)

(29) Norboletone (13–ethyl–17ß–hydroxy–18, 19–dinorpregn–4–en–3–one)

(30) Norclostebol (4–chloro–17ß–hydroxyestr–4–en–3–one)

(31) Norethandrolone (17α–ethyl–17ß–hydroxyestr–4–en–3–one)

(32) Oxabolone (4,17ß–dihydroxyestr–4–en–3–one)

(33) Oxandrolone (17ß–hydroxy–17–methyl–2–oxa–5α–androstan–3–one)

(34) Oxymesterone (4,17ß–dihydroxy–17–methylandrost–4–en–3–one)

(35) Oxymetholone (17ß–hydroxy–2–(hydroxymethylene)–17–methyl–5α–androstan–3–one)

(36) Prasterone (3ß–hydroxyandrost–5–en–17–one)

(37) Quinbolone (17ß–(1–cyclopenten–1–yloxy) androsta–1,4–dien–3–one)

(38) Stanozolol (17ß–hydroxy–17–methyl–5α–androstano [3,2–c]pyrazole)

(39) Stenbolone (17ß–hydroxy–2–methyl–5α–androst–1–en–3–one)

(40) Testosterone (17ß–hydroxyandrost–4–en–3–one)

(41) Tibolone ((7α,17α)-17–hydroxy–7–methyl–19–norpregn–5(10) en–20–yn–3–one)

(42) Tiomesterone (1α,7α–bis(acetylthio)–17ß–hydroxy–17–methylandrost–4–en–3–one)

(43) Trenbolone (17ß–hydroxyestra–4,9,11–trien–3–one)

24. Zeranol (3,4,5,6,7,8,9,10,11,12–decahydro–7,14,16–trihydroxy–3–methyl–1H–2–benzoxacyclotetradecin–1–one)

25. Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof

25.1 Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof

26. Pyrovalerone (4'-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof

27. Salvia divinorum (S. divinorum), its preparations and derivatives, including:

(1) Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)

1996, c. 19, Sch. IV; SOR/97-230, ss. 11 to 15; SOR/98-173, s. 2; SOR/99-371, s. 3; SOR/99-421, s. 2(E); SOR/2000-220, s. 2; SOR/2003-32, s. 6; SOR/2003-37; SOR/2015-209; 2017, c. 7, s. 49; SOR/2017-13, ss. 7 to 9, 10(E), 11, 12; SOR/2018-70, s. 4.

–

SCHEDULE V

(Sections 2, 5 to 7.1, 10, 55 and 60.1)

1996, c. 19, Sch. V; SOR/2002-361, s. 1; SOR/2003-32, s. 7; 2017, c. 7, s. 50.

–

SCHEDULE VI

SCHEDULE VI

(Sections 2, 6, 55 and 60)

PART 1

Class A Precursors

1 Acetic anhydride

2 N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts

3 Anthranilic acid (2-aminobenzoic acid) and its salts

4 Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts

5 Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts

6 Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts

7 Isosafrole (5-(1-propenyl)-1,3-benzodioxole)

8 Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts

9 3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone)

10 Norephedrine (Phenylpropanolamine) and its salts

11 1-Phenyl-2-propanone

12 Phenylacetic acid and its salts

13 Piperidine and its salts

14 Piperonal (1,3-benzodioxole-5-carboxaldehyde)

15 Potassium permanganate

16 Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts

17 Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole

18 Gamma-butyrolactone (dihydro-2(3H)-furanone)

19 1,4-butanediol

20 Red Phosphorus

21 White Phosphorus

22 Hypophosphorous acid, its salts and derivatives

23 Hydriodic acid

24 Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers

25 Propionyl chloride

26 1-Phenethyl-4-piperidone and its salts

27 4-Piperidone and its salts

28 Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide) and its salts

29 1-Phenethylpiperidin-4-ylidenephenylamine and its salts

30 N-Phenyl-4-piperidinamine and its salts

31 N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts

PART 2

Class B Precursors

1 Acetone

2 Ethyl ether

3 Hydrochloric acid

4 Methyl ethyl ketone

5 Sulphuric acid

6 Toluene

PART 3

Preparations and Mixtures

1 Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23, or in Part 2.

1996, c. 19, Sch. VI; SOR/2002-361, s. 2; 2005-364, ss. 1, 2, 3(F), 4; SOR/2016-13, 295; SOR/2017-277, s. 2.

–

SCHEDULE VII

[Repealed, 2018, c. 16, s. 205]

SCHEDULE VIII

[Repealed, 2018, c. 16, s. 205]

SCHEDULE IX

(Sections 2 and 60)

1. Manual, semi-automatic or fully automatic device that may be used to compact or mould powdered, granular or semi-solid material to produce coherent solid tablets

2. Manual, semi-automatic or fully automatic device that may be used to fill capsules with any powdered, granular, semi-solid or liquid material

2017, c. 7, s. 51.

–

Source

• CanLII Version